UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000013972 |
|---|---|
| Receipt number | R000016277 |
| Scientific Title | Effect of iron-contained phosphate binder on serum FGF23 in hemodialysis patients. |
| Date of disclosure of the study information | 2014/05/19 |
| Last modified on | 2014/08/27 15:55:48 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of iron-contained phosphate binder on serum FGF23 in hemodialysis patients.
Acronym
Effect of iron-contained phosphate binder on serum FGF23 in hemodialysis patients.
Scientific Title
Effect of iron-contained phosphate binder on serum FGF23 in hemodialysis patients.
Scientific Title:Acronym
Effect of iron-contained phosphate binder on serum FGF23 in hemodialysis patients.
Region
| Japan |
Condition
Condition
Chronic renal failure
Classification by specialty
| Nephrology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
We investigate serum FGF23 concentration when phosphate binder is converted for sevelamer-HCl to Ferric citrate hydtate in hemodialysis patients.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the change of serum FGF23 concentration
Key secondary outcomes
Base
Study type
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Converting of phosphate binder for sevelamer-HCl to ferric citrate hydrate in hemodialysis patients.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 90 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
hemodialysis patients with sevelamer-HCl
Key exclusion criteria
excess of iron
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Ichiei Narita |
Organization
Niigata University Medical and Dental Hospital
Division name
Department of Nephrology
Zip code
Address
1-757 Asahimachi-dori, Niigata, 951-8510 Japan
TEL
025-227-2200
naritai@med.niigata-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Akira Iguchi |
Organization
Ojiya general hospital
Division name
internal medicine
Zip code
Address
1-13-33 Honcho, Ojiya city, 947-8601
TEL
0258-83-3600
Homepage URL
igucci4444@yahoo.co.jp
Sponsor or person
Institute
Ojiya general hospital
Institute
Department
Personal name
Funding Source
Organization
Niigata University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 05 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 05 | Month | 16 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 05 | Month | 19 | Day |
Last follow-up date
| 2014 | Year | 08 | Month | 17 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2014 | Year | 05 | Month | 16 | Day |
Last modified on
| 2014 | Year | 08 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016277
